Collaboration - May 4, 2026
Moberg Pharma and Karo Healthcare expand collaboration for MOB-015/Terclara
The expanded agreement extends the existing collaboration between the companies established in November 2025, under which Karo Healthcare is responsible for marketing, distribution, and sales across 19 European markets with a combined population of approximately 500 million people.
Intellectual Property - May 4, 2026
Gradientech receives US patent allowance
Gradientech has received a Notice of Allowance in the United States for its single-use microfluidic test, a key component of the CE marked QuickMIC system.
Sweden - May 4, 2026
SwedenBIO introduces policy platform
The platform contains 34 concrete proposals for a stronger, more coordinated, and innovation-driven Sweden.
Collaboration - April 30, 2026
France and Sweden join forces to boost life science innovation
National stakeholders met at the French Residence in Stockholm on April 29 for a roundtable aimed at turning strategic dialogue in life science into concrete directions for Europe’s innovation capacity.
Biotech Business - April 30, 2026
Xbrane submits ranibizumab biosimilar candidate to FDA
The company has submitted an application for approval (BLA) to the US Food and Drug Administration for its biosimilar candidate to LUCENTIS (ranibizumab).
Financing - April 28, 2026
Ray Therapeutics raises USD 125 million, Novo Holdings doubles down on optogenetic eye gene therapy
The US company has closed an upsized, oversubscribed Series B to advance its optogenetic gene therapy pipeline for blinding retinal diseases with Novo Holdings reinforcing a strong Nordic investment footprint in late‑stage ophthalmology.
